All news from Anaesthesiology

Concentrated Naloxone Nasal Spray Can Be Treated As Medicine

According to this new study, researchers have found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular (IM) naloxone injection. The 2mg spray also maintains blood levels of naloxone more than twice as high as the 0.4mg IM levels for two hours after administration. It should therefore be highly effective in reversing opioid overdose. This is published by the scientific journal Addiction.

New Device for Remote Diagnosis Of Heart Condition

Researchers from National Research Lobachevsky University of Nizhny Novgorod (UNN) have established a software and hardware system to remotely assess deviations in heart activity and identify cardiovascular diseases at an early stage. The CyberHeart intelligent supercomputer technology is designed to serve both patients and cardiologists.

Increasing Testosterone and Make Up Professional Stock Market Traders

According to a new study in the INFORMS journal Management Science, this could be a significant contributor to fluctuations in the market, as high testosterone levels can cause these traders to overestimate future stock values and change their trading behavior, leading to dangerous prices bubbles and subsequent crashes. In the U.S. today, most of professional stock market traders are young males and new evidence suggests biology strongly influences their trading behavior.

NASA Explains Space Radiation; Study Reveals

In this study, researchers established NASA elucidates Space radiation, the Charged particles may be small, but they matter to astronauts. NASA's Human Research Program (HRP) is investigating these particles to solve one of its biggest challenges for a human journey to Mars: space radiation and its effects on the human body

Scientist Seek to Standardize Treatments for Childhood Rheumatic Diseases

Pediatric rheumatic diseases are a varied group of rare diseases including juvenile forms of arthritis, lupus, fibromyalgia, and other conditions. Currently, there is considerable variability in how patients with these diseases are treated in clinical practice, making it difficult to understand which therapies work best. A new study published in the journal Arthritis & Rheumatology examines recent efforts to address this challenge.